Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Lam, Carolyn S P

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. [electronic resource] - Circulation. Heart failure Sep 2012 - 571-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article

1941-3297

10.1161/CIRCHEARTFAILURE.112.970061 doi


Age Factors
Aged
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Biphenyl Compounds--therapeutic use
Chi-Square Distribution
Comorbidity
Female
Health Status Disparities
Heart Failure--diagnosis
Hospitalization
Humans
Irbesartan
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Proportional Hazards Models
Risk Assessment
Risk Factors
Sex Factors
Stroke Volume
Tetrazoles--therapeutic use
Time Factors
Treatment Outcome
Ventricular Function, Left